Competitive antagonists shift the dose-effect curve for an agonist (e.g. the endogenous neurotransmitter) to the right, but this effect can eventually be overcome by enough agonist concentration.

file_download Download in HQ

Related content

image Image
Non-motor symptoms common in Parkinson’s disease

A table that provides you an overview on non-motor symptoms common in Parkinson’s disease

02.04.2025 Parkinson’s Disease
The Heterogeneity of Depression and Immunometabolic Depression play_circle Video play_circle
The Heterogeneity of Depression and Immunometabolic Depression

Professor Dr. Brenda Penninx discusses the heterogeneity of major depressive disorder, with specific reference to immunometabolic depression

31.03.2025 Depression
grid_view Slide Deck
Parkinson’s Disease – Non-motor Symptom Complex and Comorbidities

In this slide deck, cognitive disorders, mood disorders, quality of life and the comorbidities of PD are discussed

16.03.2025 Parkinson’s Disease